279 related articles for article (PubMed ID: 20616583)
1. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
Kudo M; Hatanaka K; Maekawa K
Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
[TBL] [Abstract][Full Text] [Related]
3. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
Kudo M; Hatanaka K; Inoue T; Maekawa K
Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
[TBL] [Abstract][Full Text] [Related]
4. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
[TBL] [Abstract][Full Text] [Related]
6. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
[TBL] [Abstract][Full Text] [Related]
8. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
[TBL] [Abstract][Full Text] [Related]
10. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
Goto E; Masuzaki R; Tateishi R; Kondo Y; Imamura J; Goto T; Ikeda H; Akahane M; Shiina S; Omata M; Yoshida H; Koike K
J Gastroenterol; 2012 Apr; 47(4):477-85. PubMed ID: 22200940
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma.
Dohmen T; Kataoka E; Yamada I; Miura K; Ohshima S; Shibuya T; Segawa D; Sato W; Anezaki Y; Ishii H; Kamada K; Goto T; Ohnishi H
Intern Med; 2012; 51(1):1-7. PubMed ID: 22214616
[TBL] [Abstract][Full Text] [Related]
12. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
14. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y; Terae S; Shirato H
Jpn J Radiol; 2009 May; 27(4):185-93. PubMed ID: 19499310
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
[TBL] [Abstract][Full Text] [Related]
17. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic imaging of hepatocellular carcinoma: recent progress.
Kudo M
Oncology; 2011; 81 Suppl 1():73-85. PubMed ID: 22212940
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography.
Makino Y; Imai Y; Ohama H; Igura T; Kogita S; Sawai Y; Fukuda K; Takamura M; Ohashi H; Murakami T
Oncology; 2013; 84 Suppl 1():44-50. PubMed ID: 23428858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
